Revolution Medicines Ownership | Who Owns Revolution Medicines?
Revolution Medicines Ownership Summary
Revolution Medicines is owned by 110.73% institutional investors, 2.12% insiders. Vanguard group is the largest institutional shareholder, holding 10.25% of RVMD shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.94% of its assets in Revolution Medicines shares.
RVMD Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Revolution Medicines | 110.73% | 2.12% | -12.85% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Vanguard group | 17.10M | 10.25% | $747.80M |
Blackrock funding, inc. /de | 14.72M | 8.82% | $643.83M |
Farallon capital management | 13.25M | 7.94% | $579.50M |
Wellington management group llp | 10.82M | 6.49% | $473.34M |
Janus henderson group | 9.48M | 5.68% | $414.78M |
Baker bros. advisors lp | 7.94M | 4.76% | $347.16M |
Nextech invest | 7.60M | 4.56% | $332.47M |
Fmr | 6.74M | 4.04% | $294.90M |
Paradigm biocapital advisors lp | 6.55M | 3.93% | $286.63M |
Price t rowe associates inc /md/ | 5.87M | 3.52% | $256.58M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Mass general brigham | 338.19K | 63.90% | $13.13M |
Nextech invest | 7.60M | 53.94% | $332.47M |
Lunate rsc | 2.20M | 45.54% | $96.06M |
Ah capital management | 2.75M | 16.13% | $120.22M |
Casdin capital | 3.70M | 10.77% | $161.81M |
Alphabet | 4.13M | 10.53% | $180.79M |
Paradigm biocapital advisors lp | 6.55M | 9.97% | $286.63M |
Boxer capital | 4.28M | 8.75% | $166.09M |
Logos global management lp | 1.45M | 7.42% | $63.42M |
Dafna capital management | 631.18K | 7.02% | $27.61M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Janus henderson group | 9.48M | 0.21% | 3.35M |
Lunate rsc | 2.20M | 45.54% | 2.20M |
Vanguard group | 17.10M | 0.01% | 2.19M |
Farallon capital management | 13.25M | 2.94% | 1.93M |
Norges bank | 1.74M | 0.01% | 1.74M |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Perceptive advisors | - | - | -618.88K |
Wellington management group llp | 10.82M | 0.09% | -579.70K |
Soleus capital management | 201.08K | 0.55% | -503.50K |
Bellevue group | 4.39M | 3.69% | -484.46K |
Casdin capital | 3.70M | 10.77% | -415.00K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Lunate rsc | 2.20M | 45.54% | 2.20M | $96.06M |
Norges bank | 1.74M | 0.01% | 1.74M | $76.20M |
Raymond james financial | 321.61K | 0.01% | 321.61K | $14.07M |
Ghisallo capital management | 257.10K | 0.65% | 257.10K | $11.25M |
Bnp paribas arbitrage, snc | 248.33K | 0.01% | 248.33K | $10.86M |
Sold Out
Holder | Change |
---|---|
Advisornet financial | -6.00 |
Riverview trust | -12.00 |
Capital performance advisors llp | -16.00 |
Quest partners | -18.00 |
Nelson, van denburg & campbell wealth management group | -27.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 277 | 5.73% | 184,740,316 | 9.37% | 110 | 1.08% | 179 | 20.95% | 52 | -16.13% |
Sep 30, 2024 | 260 | 14.54% | 168,886,065 | 0.30% | 101 | 973278.73% | 148 | 18.40% | 62 | 8.77% |
Jun 30, 2024 | 227 | 4.13% | 168,384,927 | 6.00% | - | 1101.87% | 125 | 20.19% | 57 | -13.64% |
Mar 31, 2024 | 218 | 9.00% | 158,856,105 | -0.68% | - | 1024.97% | 104 | -25.18% | 66 | 88.57% |
Dec 31, 2023 | 200 | 9.29% | 159,946,965 | 42.78% | - | 2105.90% | 139 | 31.13% | 35 | -10.26% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 5.47M | 2.94% | 3.66K |
Vanguard US Total Market Shares ETF | 4.74M | 2.55% | 4.24K |
iShares Russell 2000 ETF | 4.48M | 2.41% | -38.77K |
Vanguard Small Cap Index | 4.42M | 2.38% | 3.64K |
BB Biotech AG Ord | 4.37M | 2.37% | -484.46K |
Vanguard Health Care Inv | 4.30M | 2.32% | -1.19M |
Vanguard Institutional Extnd Mkt Idx Tr | 2.61M | 1.40% | 3.70K |
Vanguard Small Cap Growth Index Inv | 2.48M | 1.34% | -13.58K |
US Small-Cap Growth II Equity Comp | 2.22M | 1.20% | 95.29K |
Janus Henderson Enterprise D | 2.03M | 1.09% | 171.50K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Mar 20, 2025 | Cislini Jeff | General Counsel | Sell | $79.01K |
Mar 17, 2025 | Cislini Jeff | General Counsel | Sell | $56.92K |
Mar 17, 2025 | GOLDSMITH MARK A | See Remarks | Sell | $458.26K |
Mar 17, 2025 | Anders Jack | Chief Financial Officer | Sell | $72.77K |
Mar 17, 2025 | Horn Margaret A | Chief Operating Officer | Sell | $119.39K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | 6 |
2024 Q4 | 2 | 23 |
2024 Q3 | - | 20 |
2024 Q2 | - | 19 |
2024 Q1 | - | 12 |
RVMD Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools